Critical Care
Sepsis & Septic Shock Cascade
From infection to organ failure — cytokines, vasodilation, capillary leak, MAP collapse
Infection triggers a runaway host response: cytokines, nitric oxide, capillary leak, falling blood pressure, organ failure. Septic shock — MAP < 65 needing vasopressors plus lactate > 2 — kills 40–50% of patients.
- Septic shock mortality40–50%
- MAP target≥ 65 mmHg with vasopressors
- Lactate threshold> 2 mmol/L defines shock; > 4 high risk
- Antibiotic delay penalty+7.6% mortality per hour
- Main mediatorsTNF-α, IL-1β, IL-6, NO, complement
- First-line pressorNorepinephrine
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
The cascade — stage by stage
- Recognition. Macrophages and dendritic cells detect pathogen-associated molecular patterns — LPS from Gram-negatives via TLR4, peptidoglycan via TLR2, flagellin via TLR5, microbial DNA via TLR9. PAMPs trigger NF-κB activation within minutes.
- Cytokine release. TNF-α, IL-1β, and IL-6 are secreted within 1–2 hours. They activate distant immune cells and signal through endothelium throughout the body.
- Endothelial activation. Endothelial cells upregulate adhesion molecules, lose barrier integrity, and induce iNOS — inducible nitric oxide synthase. Nitric oxide diffuses into vascular smooth muscle and relaxes it.
- Massive vasodilation. Systemic vascular resistance crashes. Despite high cardiac output, perfusion pressure falls. The patient is warm, flushed, with bounding pulses — "warm shock."
- Capillary leak. Endothelial gaps let plasma escape into the interstitium. Effective circulating volume drops further; intravascular fluid needs constant replacement.
- Lactate rise. Tissue oxygen delivery and utilization fail despite cardiac output. Anaerobic metabolism produces lactate; levels above 2 mmol/L define shock, above 4 are high-risk.
- MAP collapse. Mean arterial pressure falls below 65 mmHg — the threshold for organ perfusion. Fluids alone cannot maintain it.
- Multi-organ failure. Acute kidney injury, ARDS, encephalopathy, hepatic dysfunction, ileus, DIC. SOFA score rises.
Worked example — hour-1 sepsis bundle
A 72-year-old presents with cough, fever, and confusion. Initial vitals: HR 124, BP 86/52, RR 28, T 38.9°C, O2 sat 88% on room air. Lactate ordered, draws back at 3.4 mmol/L. Diagnosis: sepsis with hypotension; cannot yet differentiate sepsis vs septic shock until fluid response is known.
- T = 0 (hour-1 bundle begins): Two large-bore IVs placed. Blood cultures × 2 drawn before antibiotics.
- T = 20 min: Broad-spectrum antibiotic in — empiric pip-tazo for community-acquired pneumonia coverage in a patient with no MRSA risk factors. Each hour of delay would add ~7.6% mortality.
- T = 30 min: 30 mL/kg crystalloid begun — 2.4 L for this 80 kg patient.
- T = 60 min: BP recheck — still 82/50 despite 2 L. MAP ≈ 61. Norepinephrine started at 5 μg/min, titrated to MAP ≥ 65. Repeat lactate at 2 hr: 2.8 mmol/L (improving).
- T = 2 hr: Patient meets septic shock criteria — needs vasopressors plus lactate > 2. Mortality risk now in the 40–50% band.
- T = 6 hr: Lactate clearance 60% from peak — favorable. Source identified as pneumonia on chest CT. ICU admission.
This sequence — exactly captured in the Surviving Sepsis 2021 guidelines — is the difference between survival rates of ~60% (with bundle) and ~40% (without).
Why earlier "early goal-directed therapy" failed and what replaced it
Rivers et al. published EGDT in 2001 showing dramatic mortality reduction with a protocol of central-line ScvO2 monitoring, aggressive transfusion, and inotropes. Three large trials (ProCESS, ARISE, ProMISe) in the 2010s found no mortality benefit from formal EGDT compared with usual care — but usual care had improved dramatically because everyone now gave fluids and antibiotics fast. The current Surviving Sepsis bundle is the distilled, evidence-based residue: cultures, antibiotics, fluids, pressors, abandoning the strict CVP and ScvO2 targets that EGDT prescribed. Speed of action matters more than the precise hemodynamic gymnastics.
Clinical implications
- Recognition tools. qSOFA (RR ≥ 22, altered mentation, SBP ≤ 100) flags high-risk ward patients but misses many cases; NEWS2 and machine-learning early-warning systems perform better.
- Source control. Drain abscesses, remove infected catheters, debride necrotic tissue. No volume of antibiotic salvages an unsource-controlled infection.
- Fluid choice. Balanced crystalloids (lactated Ringer's, Plasma-Lyte) over normal saline; avoid hydroxyethyl starches (proven harm). Albumin reasonable in patients needing large volumes.
- Pressor escalation. Norepinephrine first; add vasopressin at norepinephrine 0.25 μg/kg/min; epinephrine third-line; hydrocortisone 200 mg/day for refractory shock.
- Ventilator strategy. Low tidal volume (6 mL/kg ideal body weight), permissive hypercapnia, prone positioning for ARDS.
- Renal management. Avoid nephrotoxins; consider continuous renal replacement if hemodynamically unstable with AKI requiring dialysis.
- Outcomes. 30-day mortality 20% for sepsis, 40–50% for septic shock. Post-sepsis syndrome — cognitive impairment, weakness, recurrent infections — affects survivors for years.
Common misconceptions
- "Fluids fix shock." Fluids restore intravascular volume but cannot reverse pathologic vasodilation; vasopressors are required when MAP cannot be sustained.
- "Vasopressors should wait until fluids are maxed out." Delaying pressors prolongs hypoperfusion; current practice starts norepinephrine peripherally if needed while continuing fluids.
- "High WBC means infection severity." Patients can be neutropenic or have a normal count in sepsis; bandemia and immature forms are more informative.
- "Negative blood cultures mean no infection." Up to 30–40% of sepsis cases are culture-negative; treat empirically based on suspected source.
- "Steroids should be given to everyone in septic shock." Evidence supports them only in vasopressor-refractory shock; routine use does not improve mortality.
- "Lactate is just from poor perfusion." Some elevation reflects epinephrine-driven glycolysis; persistent levels above 2 mmol/L still carry prognostic weight regardless of mechanism.
| Stage | Definition | Hemodynamics | Lactate | Mortality | Key intervention |
|---|---|---|---|---|---|
| Local infection | localized inflammation | normal | normal | low | targeted antibiotic |
| Bacteremia | bacteria in blood without organ dysfunction | often normal | often normal | variable | antibiotic + source control |
| Sepsis | infection + SOFA Δ ≥ 2 | may be hypotensive | often elevated | ~10–20% | hour-1 bundle |
| Septic shock | sepsis + vasopressor for MAP ≥ 65 + lactate > 2 | requires pressors | > 2 mmol/L | ~40–50% | norepinephrine + ICU |
| Refractory shock | norepinephrine > 0.5 μg/kg/min | multiple pressors | often > 4 | ~60–80% | vasopressin, steroids, source review |
| MODS | multi-organ dysfunction | variable | variable | up to 80%+ | supportive ICU care, organ replacement |
Frequently asked questions
What defines sepsis vs septic shock?
Sepsis-3 (2016): sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. Operationally, suspected infection plus an acute rise in SOFA score of ≥ 2 points. Septic shock is the subset of sepsis with persistent hypotension requiring vasopressors to maintain MAP ≥ 65 mmHg AND a lactate > 2 mmol/L despite adequate volume resuscitation. Mortality: sepsis ~10-20%, septic shock ~40-50%. The older SIRS criteria are sensitive but non-specific and have largely been replaced for clinical sepsis identification.
What drives the vasodilation?
Endotoxin (LPS in Gram-negatives) and other pathogen-associated molecular patterns activate macrophages via Toll-like receptors. They release TNF-α, IL-1β, and IL-6, which drive endothelial induction of inducible nitric oxide synthase (iNOS). Nitric oxide causes profound smooth-muscle relaxation and systemic vasodilation. Reactive oxygen species, complement activation (C3a, C5a), bradykinin, and prostacyclin all add to the picture. The net effect is high cardiac output but catastrophically low systemic vascular resistance — 'warm shock' with bounding pulses and low blood pressure.
Why does lactate matter?
Lactate > 2 mmol/L is part of the septic shock definition. It reflects anaerobic metabolism due to tissue hypoperfusion — capillary leak and vasodilation make oxygen delivery insufficient even at normal cardiac output. Lactate > 4 mmol/L is associated with markedly higher mortality. Lactate clearance over the first 6 hours of resuscitation correlates with survival. Some increase comes from epinephrine-driven glycolysis rather than hypoperfusion, but persistent elevation in sepsis is a red flag.
What is the hour-1 bundle?
Surviving Sepsis Campaign's time-critical interventions, originally targeted at 3 and 6 hours, consolidated into a 1-hour bundle: (1) measure lactate, (2) draw blood cultures before antibiotics, (3) give broad-spectrum antibiotic within 1 hour of recognition, (4) start 30 mL/kg crystalloid fluid for hypotension or lactate ≥ 4, (5) start vasopressors for MAP < 65 after fluid. Each hour of antibiotic delay raises mortality by ~7.6%. Sequential implementation in EDs and ICUs has reduced absolute mortality by several percentage points.
Which vasopressor is first-line?
Norepinephrine — predominant α1-agonist with mild β1 — is first-line for septic shock per Surviving Sepsis guidelines. Vasopressin is added at 0.03 U/min when norepinephrine doses exceed ~0.25 μg/kg/min, sparing catecholamine dose and acting through V1 receptors. Epinephrine is third-line. Dopamine is no longer recommended (more arrhythmias, no mortality benefit). Phenylephrine has a role in tachyarrhythmia-prone patients. Steroids (hydrocortisone 200 mg/day) are added in refractory shock.
Why do organs fail?
Multiple mechanisms. Microcirculatory failure — capillary leak, endothelial dysfunction, microthrombi — reduces tissue oxygen delivery even when macroscopic blood pressure is restored. Mitochondrial dysfunction limits oxygen utilization at the cellular level. Complement and coagulation cascades cause disseminated intravascular coagulation. Direct cellular injury from cytokines and reactive species. The kidneys (acute tubular necrosis), lungs (ARDS), liver, brain (encephalopathy), and gut are typically first hit. Multi-organ dysfunction is the proximate cause of death in most septic shock fatalities.
Is sepsis biology really 'dysregulated'?
Yes. A normal immune response is localized — recruits cells to the infection site and resolves inflammation as the pathogen clears. In sepsis the response becomes systemic and self-amplifying: cytokines drive more cytokines, endothelium activates throughout the body, coagulation activates without sufficient counter-regulation. Later phases show paradoxical immunosuppression — apoptosis of lymphocytes, exhausted T cells, susceptibility to secondary infections. Both pro- and anti-inflammatory dysregulation contribute; the relative balance shifts over time.